AAAAAA

   
Results: 1-25 | 26-45
Results: 1-25/45
High incidence of N and K-Ras activating mutations in multiple myeloma andprimary plasma cell leukemia at diagnosis
Authors: Bezieau, S Devilder, MC Avet-Loiseau, H Mellerin, MP Puthier, D Pennarun, E Rapp, MJ Harousseau, JL Moisan, JP Bataille, R
Citation: S. Bezieau et al., High incidence of N and K-Ras activating mutations in multiple myeloma andprimary plasma cell leukemia at diagnosis, HUM MUTAT, 18(3), 2001, pp. 212-224
IL-6 upregulates its own receptor on some human myeloma cell lines
Authors: Thabard, W Collette, M Mellerin, MP Puthier, D Barille, S Bataille, R Amiot, M
Citation: W. Thabard et al., IL-6 upregulates its own receptor on some human myeloma cell lines, CYTOKINE, 14(6), 2001, pp. 352-356
Protein kinase C delta and eta isoenzymes control the shedding of the interleukin 6 receptor alpha in myeloma cells
Authors: Thabard, W Collette, M Bataille, R Amiot, M
Citation: W. Thabard et al., Protein kinase C delta and eta isoenzymes control the shedding of the interleukin 6 receptor alpha in myeloma cells, BIOCHEM J, 358, 2001, pp. 193-200
Interferon alpha extends the survival of human myeloma cells through an upregulation of the Mcl-1 anti-apoptotic molecule
Authors: Puthier, D Thabard, W Rapp, MJ Etrillard, M Harousseau, JL Bataille, R Amiot, M
Citation: D. Puthier et al., Interferon alpha extends the survival of human myeloma cells through an upregulation of the Mcl-1 anti-apoptotic molecule, BR J HAEM, 112(2), 2001, pp. 358-363
Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment
Authors: Giuliani, N Bataille, R Mancini, C Lazzaretti, M Barille, S
Citation: N. Giuliani et al., Myeloma cells induce imbalance in the osteoprotegerin/osteoprotegerin ligand system in the human bone marrow environment, BLOOD, 98(13), 2001, pp. 3527-3533
Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors
Authors: Avet-Loiseau, H Gerson, F Magrangeas, F Minvielle, S Harousseau, JL Bataille, R
Citation: H. Avet-loiseau et al., Rearrangements of the c-myc oncogene are present in 15% of primary human multiple myeloma tumors, BLOOD, 98(10), 2001, pp. 3082-3086
Chromosome 13 abnormalities identified by FISH analysis and serum beta(2)-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy
Authors: Facon, T Avet-Loiseau, H Guillerm, G Moreau, P Genevieve, F Zandecki, M Lai, JL Leleu, X Jouet, JP Bauters, F Harousseau, JL Bataille, R Mary, JY
Citation: T. Facon et al., Chromosome 13 abnormalities identified by FISH analysis and serum beta(2)-microglobulin produce a powerful myeloma staging system for patients receiving high-dose therapy, BLOOD, 97(6), 2001, pp. 1566-1571
Interleukin-6 is a growth factor for nonmalignant human plasmablasts
Authors: Jego, G Bataille, R Pellat-Deceunynck, C
Citation: G. Jego et al., Interleukin-6 is a growth factor for nonmalignant human plasmablasts, BLOOD, 97(6), 2001, pp. 1817-1822
Cytogenetic, interphase, and multicolor fluorescence in situ hybridizationanalyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myelome and the Groupe Francais de Cytogenetique Hematologique
Authors: Avet-Loiseau, H Daviet, A Brigaudeau, C Callet-Bauchu, E Terre, C Lafage-Pochitaloff, M Desangles, F Ramond, S Talmant, P Bataille, R
Citation: H. Avet-loiseau et al., Cytogenetic, interphase, and multicolor fluorescence in situ hybridizationanalyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myelome and the Groupe Francais de Cytogenetique Hematologique, BLOOD, 97(3), 2001, pp. 822-825
The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma
Authors: Barille, S Bataille, R Amiot, M
Citation: S. Barille et al., The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma, EUR CYTOKIN, 11(4), 2000, pp. 546-551
Deletion of 5q31 is observed in megakaryocytic cells in patients with myelodysplastic syndromes and a del(5q), including the 5q-syndrome
Authors: Godon, C Talmant, P Garand, R Accart, F Bataille, R Avet-Loiseau, H
Citation: C. Godon et al., Deletion of 5q31 is observed in megakaryocytic cells in patients with myelodysplastic syndromes and a del(5q), including the 5q-syndrome, GENE CHROM, 29(4), 2000, pp. 350-352
Soluble IL-6R alpha upregulates IL-6, MMP-1 and MMP-2 secretion in bone marrow stromal cells
Authors: Barille, S Collette, M Thabard, W Bleunven, C Bataille, R Amiot, M
Citation: S. Barille et al., Soluble IL-6R alpha upregulates IL-6, MMP-1 and MMP-2 secretion in bone marrow stromal cells, CYTOKINE, 12(9), 2000, pp. 1426-1429
Future production systems: Influence of self-organization on approaches toquality engineering
Authors: Massotte, P Bataille, R
Citation: P. Massotte et R. Bataille, Future production systems: Influence of self-organization on approaches toquality engineering, INT J PRO E, 64(1-3), 2000, pp. 359-377
Lack of benefit of CD34(+) cell selected over non-selected peripheral blood stem cell transplantation in multiple myeloma: results of a single centerstudy
Authors: Morineau, N Tang, XW Moreau, P Milpied, N Mahe, B Bataille, R Harousseau, JL
Citation: N. Morineau et al., Lack of benefit of CD34(+) cell selected over non-selected peripheral blood stem cell transplantation in multiple myeloma: results of a single centerstudy, LEUKEMIA, 14(10), 2000, pp. 1815-1820
Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia
Authors: Le Gouill, S Talmant, P Milpied, N Daviet, A Ancelot, M Moreau, P Harousseau, JL Bataille, R Avet-Loiseau, H
Citation: S. Le Gouill et al., Fluorescence in situ hybridization on peripheral-blood specimens is a reliable method to evaluate cytogenetic response in chronic myeloid leukemia, J CL ONCOL, 18(7), 2000, pp. 1533-1538
Reactive plasmacytoses in multiple myeloma during hematopoietic recovery with G- or GM-CSF
Authors: Jego, G Avet-Loiseau, H Robillard, N Moreau, P Amiot, M Harousseau, JL Pellat-Deceunynck, C Bataille, R
Citation: G. Jego et al., Reactive plasmacytoses in multiple myeloma during hematopoietic recovery with G- or GM-CSF, LEUK RES, 24(7), 2000, pp. 627-630
The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressedby human myeloma cells
Authors: Pellat-Deceunynck, C Mellerin, MP Labarriere, N Jego, G Moreau-Aubry, A Harousseau, JL Jotereau, F Bataille, R
Citation: C. Pellat-deceunynck et al., The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressedby human myeloma cells, EUR J IMMUN, 30(3), 2000, pp. 803-809
Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13
Authors: Avet-Loiseau, H Daviet, A Saunier, S Bataille, R
Citation: H. Avet-loiseau et al., Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13, BR J HAEM, 111(4), 2000, pp. 1116-1117
A combination of anti-interleukin 6 murine monoclonal antibody with dexamethasone and high-dose melphalan induces high complete response rates in advanced multiple myeloma
Authors: Moreau, P Harousseau, JL Wijdenes, J Morineau, N Milpied, N Bataille, R
Citation: P. Moreau et al., A combination of anti-interleukin 6 murine monoclonal antibody with dexamethasone and high-dose melphalan induces high complete response rates in advanced multiple myeloma, BR J HAEM, 109(3), 2000, pp. 661-664
IgG-secreting lymphoplasmacytoid leukaemia: a B-cell disorder with extensively mutated V-H genes undergoing Ig isotype-switching frequently associated with trisomy 12
Authors: Garand, R Sahota, SS Avet-Loiseau, H Talmant, P Robillard, N Moreau, A Gaillard, F Stevenson, FK Bataille, R
Citation: R. Garand et al., IgG-secreting lymphoplasmacytoid leukaemia: a B-cell disorder with extensively mutated V-H genes undergoing Ig isotype-switching frequently associated with trisomy 12, BR J HAEM, 109(1), 2000, pp. 71-80
Synovial membrane metaplasia to secondary lymphoid organs: Role in the pathogenesis of auto-immune arthritis
Authors: Berthelot, JM Bataille, R Maugars, Y Prost, A
Citation: Jm. Berthelot et al., Synovial membrane metaplasia to secondary lymphoid organs: Role in the pathogenesis of auto-immune arthritis, REV RHUM, 66(7-9), 1999, pp. 410-418
Isolation of human lymphocyte antigens class I-restricted cytotoxic T lymphocytes against autologous myeloma cells
Authors: Pellat-Deceunynck, C Jego, G Harousseau, JL Vie, H Bataille, R
Citation: C. Pellat-deceunynck et al., Isolation of human lymphocyte antigens class I-restricted cytotoxic T lymphocytes against autologous myeloma cells, CLIN CANC R, 5(3), 1999, pp. 705-709
Validation of Bi-213-alpha radioimmunotherapy for multiple myeloma
Authors: Couturier, O Faivre-Chauvet, A Filippovich, IV Thedrez, P Sai-Maurel, C Bardies, M Mishra, AK Gauvrit, M Blain, G Apostolidis, C Molinet, R Abbe, JC Bataille, R Wijdenes, J Chatal, JF Cherel, M
Citation: O. Couturier et al., Validation of Bi-213-alpha radioimmunotherapy for multiple myeloma, CLIN CANC R, 5(10), 1999, pp. 3165S-3170S
Myeloma cells release soluble interleukin-6R alpha in relation to disease progression by two distinct mechanisms: Alternative splicing and proteolytic cleavage
Authors: Thabard, W Barille, S Collette, M Harousseau, JL Rapp, MJ Bataille, R Amiot, M
Citation: W. Thabard et al., Myeloma cells release soluble interleukin-6R alpha in relation to disease progression by two distinct mechanisms: Alternative splicing and proteolytic cleavage, CLIN CANC R, 5(10), 1999, pp. 2693-2697
Amplification of the IIq23 region in acute myeloid leukemia
Authors: Avet-Loiseau, H Godon, C Li, JY Daviet, A Mellerin, MP Talmant, P Harousseau, JL Bataille, R
Citation: H. Avet-loiseau et al., Amplification of the IIq23 region in acute myeloid leukemia, GENE CHROM, 26(2), 1999, pp. 166-170
Risultati: 1-25 | 26-45